These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 3841578

  • 21. Protective drugs in the treatment of gastroduodenal ulcer disease.
    Koelz HR.
    Scand J Gastroenterol Suppl; 1986; 125():156-64. PubMed ID: 3547612
    [Abstract] [Full Text] [Related]

  • 22. [Ulcer healing without acid inhibition].
    Koelz HR.
    Dtsch Med Wochenschr; 1985 May 17; 110(20):806-9. PubMed ID: 2859974
    [No Abstract] [Full Text] [Related]

  • 23. [Progress in the pharmacotherapy of peptic ulcer].
    Stasiewicz J, Moniuszko-Jakoniuk J.
    Pol Tyg Lek; 1985 May 17; 39(51-52):1721-5. PubMed ID: 6151657
    [No Abstract] [Full Text] [Related]

  • 24. Effects of 12-sulfodehydroabietic acid monosodium salt (TA-2711), a new anti-ulcer agent, on gastric secretion and experimental ulcers in rats.
    Onoda Y, Magaribuchi T, Tamaki H.
    Jpn J Pharmacol; 1989 Sep 17; 51(1):65-73. PubMed ID: 2509775
    [Abstract] [Full Text] [Related]

  • 25. Sucralfate, bismuth compounds, substituted benzimidazoles, trimipramine and pirenzepine in the short- and long-term treatment of duodenal ulcer.
    Tytgat GN, Hameeteman W, van Olffen GH.
    Clin Gastroenterol; 1984 May 17; 13(2):543-68. PubMed ID: 6378446
    [No Abstract] [Full Text] [Related]

  • 26. Sucralfate, bismuth subcitrate, and gastric HCO3 in humans.
    Guslandi M.
    Gut; 1990 Aug 17; 31(8):958-9. PubMed ID: 2387525
    [No Abstract] [Full Text] [Related]

  • 27. Effect of food and antacid on binding of sucralfate to normal and ulcerated gastric and duodenal mucosa in rats.
    Giesing DH, Bighley LD, Iles RL.
    J Clin Gastroenterol; 1981 Aug 17; 3(Suppl 2):111-6. PubMed ID: 6895642
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Effects of colloidal bismuth subcitrate and aluminum hydroxide on gastric and duodenal levels of prostaglandin E2].
    Estela R, Feller A, Backhouse C, Castro R, Ugarte G.
    Rev Med Chil; 1984 Oct 17; 112(10):975-81. PubMed ID: 6399150
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Medical treatment of peptic ulcers.
    Deveney CW, Deveney KE.
    Surg Annu; 1985 Oct 17; 17():219-33. PubMed ID: 3883541
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Antisecretory and mucosa-protecting drugs in the acute care of peptic ulcer. Review of action principles, healing rates and side effects of approved ulcer drugs and drugs under clinical trial].
    Simon B, Müller P, Dammann HG.
    Fortschr Med; 1984 Jul 12; 102(25-26):683-7. PubMed ID: 6147304
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. A potential mechanism of action of colloidal bismuth subcitrate: diffusion barrier to hydrochloric acid.
    Lee SP.
    Scand J Gastroenterol Suppl; 1982 Jul 12; 80():17-21. PubMed ID: 6962540
    [Abstract] [Full Text] [Related]

  • 39. Medical management of peptic ulcer.
    Misiewicz JJ.
    Postgrad Med J; 1984 Nov 12; 60(709):751-9. PubMed ID: 6095240
    [No Abstract] [Full Text] [Related]

  • 40. Gastrocytoprotection by colloidal bismuth subcitrate (De-Nol) and sucralfate. Role of endogenous prostaglandins.
    Konturek SJ, Radecki T, Piastucki I, Brzozowski T, Drozdowicz D.
    Gut; 1987 Feb 12; 28(2):201-5. PubMed ID: 3470240
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.